
BON Valuation
Bon Natural Life Ltd
- Overview
- Forecast
- Valuation
- Earnings
BON Relative Valuation
BON's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BON is overvalued; if below, it's undervalued.
Historical Valuation
Bon Natural Life Ltd (BON) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.09 is considered Undervalued compared with the five-year average of 5.37. The fair price of Bon Natural Life Ltd (BON) is between 26.84 to 28.29 according to relative valuation methord. Compared to the current price of 1.42 USD , Bon Natural Life Ltd is Undervalued By 94.72%.
Relative Value
Fair Zone
26.84-28.29
Current Price:1.42
94.72%
Undervalued
0.00
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Bon Natural Life Ltd. (BON) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 1.79. The thresholds are as follows: Strongly Undervalued below -3.08, Undervalued between -3.08 and -0.65, Fairly Valued between 4.22 and -0.65, Overvalued between 4.22 and 6.65, and Strongly Overvalued above 6.65. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.
1.42
EV/EBIT
Bon Natural Life Ltd. (BON) has a current EV/EBIT of 1.42. The 5-year average EV/EBIT is 2.14. The thresholds are as follows: Strongly Undervalued below -2.13, Undervalued between -2.13 and 0.00, Fairly Valued between 4.28 and 0.00, Overvalued between 4.28 and 6.42, and Strongly Overvalued above 6.42. The current Forward EV/EBIT of 1.42 falls within the Historic Trend Line -Fairly Valued range.
0.09
PS
Bon Natural Life Ltd. (BON) has a current PS of 0.09. The 5-year average PS is 0.35. The thresholds are as follows: Strongly Undervalued below -0.48, Undervalued between -0.48 and -0.07, Fairly Valued between 0.77 and -0.07, Overvalued between 0.77 and 1.18, and Strongly Overvalued above 1.18. The current Forward PS of 0.09 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Bon Natural Life Ltd. (BON) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Bon Natural Life Ltd. (BON) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Bon Natural Life Ltd (BON) has a current Price-to-Book (P/B) ratio of 0.01. Compared to its 3-year average P/B ratio of 0.18 , the current P/B ratio is approximately -97.20% higher. Relative to its 5-year average P/B ratio of 0.64, the current P/B ratio is about -99.19% higher. Bon Natural Life Ltd (BON) has a Forward Free Cash Flow (FCF) yield of approximately -148.00%. Compared to its 3-year average FCF yield of -289.48%, the current FCF yield is approximately -48.87% lower. Relative to its 5-year average FCF yield of -209.36% , the current FCF yield is about -29.31% lower.
0.01
P/B
Median3y
0.18
Median5y
0.64
-145.24
FCF Yield
Median3y
-289.48
Median5y
-209.36
Competitors Valuation Multiple
The average P/S ratio for BON's competitors is 7.28, providing a benchmark for relative valuation. Bon Natural Life Ltd Corp (BON) exhibits a P/S ratio of 0.09, which is -98.75% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of BON increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of BON in the past 1 year is driven by Unknown.
People Also Watch

MBRX
Moleculin Biotech Inc
0.392
USD
-0.25%

EDSA
Edesa Biotech Inc
2.320
USD
-2.93%

SNGX
Soligenix Inc
3.100
USD
+1.31%

EJH
E-Home Household Service Holdings Ltd
1.130
USD
-3.17%

GSUN
Golden Sun Health Technology Group Ltd
2.830
USD
+1.07%

LXEH
Lixiang Education Holding Co Ltd
2.020
USD
+2.02%

SBFM
Sunshine Biopharma Inc
1.440
USD
-3.36%

VERB
Verb Technology Company Inc
14.500
USD
+2.76%

YGMZ
MingZhu Logistics Holdings Ltd
1.010
USD
+12.10%
FAQ

Is Bon Natural Life Ltd (BON) currently overvalued or undervalued?
Bon Natural Life Ltd (BON) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.09 is considered Undervalued compared with the five-year average of 5.37. The fair price of Bon Natural Life Ltd (BON) is between 26.84 to 28.29 according to relative valuation methord. Compared to the current price of 1.42 USD , Bon Natural Life Ltd is Undervalued By 94.72% .

What is Bon Natural Life Ltd (BON) fair value?

How does BON's valuation metrics compare to the industry average?

What is the current P/B ratio for Bon Natural Life Ltd (BON) as of Aug 30 2025?

What is the current FCF Yield for Bon Natural Life Ltd (BON) as of Aug 30 2025?

What is the current Forward P/E ratio for Bon Natural Life Ltd (BON) as of Aug 30 2025?
